Katharina Lampichler

机构：Medical University of Vienna · ORCID：0000-0002-9719-4694

发表论文 60 篇 · 总被引 1152 次 · h-index 16

代表论文

• Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy (2024 · Hepatology · 被引 37)
• Study protocol: Fecal Microbiota Transplant combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma who failed to achieve or maintain objective response to Atezolizumab/Bevacizumab – the FAB-HCC pilot study (2025 · PLoS ONE · 被引 12)
• Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis (2023 · JHEP Reports · 被引 7)
• Transversal psoas muscle thickness measurement is associated with response and survival in patients with HCC undergoing immunotherapy (2023 · Hepatology Communications · 被引 7)
• Metabolomic profiles differentiate between porto-sinusoidal vascular disorder, cirrhosis, and healthy individuals (2024 · JHEP Reports · 被引 5)
• OS-112-YI Outcome and management of patients with hepatocellular carcinoma who achieved complete response to immunotherapybased systemic therapy (2024 · Journal of Hepatology · 被引 4)